Part of the study groups suggested that a reduction in the quantity of CD9 correlates with progression of oral leukoplakia into a malignant process [62]; however, the study of Wang in 2019 [92] concluded that CD9 inhibits the progression of potentially malignant processes. Here, CD9 is linked to Oral leukoplakia.